Working... Menu
Trial record 42 of 47 for:    Parasomnias | ( Map: Japan )

Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00152997
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : October 31, 2013
Information provided by:
Boehringer Ingelheim

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2005
  Study Completion Date : No date given